The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
The following is a guest article by Dmitrii Evstiukhin, Director of Managed Services at Provectus
In today’s world, personalized and efficient digital interactions are expected, especially in the healthcare industry. To meet those demands, organizations…
By Jill McKeon March 16, 2023 – Miami, Florida-based Independent Living Systems (ILS) disclosed a healthcare data breach that impacted more than 4 million individuals, making it the largest reported healthcare data…
Continue Reading
By Sara Heath March 16, 2023 – The affordable housing crisis might impact patient health, with new data from the UCLA David Geffen School of Medicine showing that moving because rent gets…
Continue Reading
ChristianaCare, a health system with headquarters in Delaware, on Tuesday launched a direct-to-consumer virtual primary care practice. The new service was rolled out to help increase access to round-the-clock, convenient primary care, as many…
Continue Reading
What You Should Know:– OpenLoop, a leader in white-label telehealth support services powering virtual and hybrid care across the country, today announced it has raised a $15M Series A funding.– The round was led…
Continue Reading
South Korea’s Ministry of Health and Welfare has released its report on the conduct of temporary telemedicine during the height of the COVID-19 pandemic.FINDINGS
According to the report, over 25,000 medical institutions provided remote treatment…
Ask people what is wrong with the healthcare system and you’ll get 10 different answers. But if there’s one thing that everyone can get behind it’s that we need to accelerate innovation and cut…
Continue Reading
The telehealth flexibilities allowed during the Covid-19 public health emergency greatly expanded access to healthcare services. But after the public health emergency ends, it’s ultimately up to Congress to further extend these flexibilities, said…
Continue Reading
Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement Tuesday comes two weeks…
Continue Reading
